S

Smart Immune, hematopoietic stem cell-based biotherapies

30 employees

Smart Immune is a biotech company that helps fight against cancer and infection by providing a thymus-empowered T-cell therapy platform.

Basic info

Industry

biotechnology research

Sectors

T cell progenitors
Biotechnology
NK cells
Cell therapy
Lymphoid progenitors
CAR T
Naive cells
Immune reconstitution
T cells
Immuno-oncology
HSC differentiation
Health Care
Therapeutics
Thymic selection
Life Science

Date founded

2017

Funding rounds raised

Total raised

$5M

from 2 investors over 2 rounds

S

Smart Immune, hematopoietic stem cell-based biotherapies raised $5M on April 16, 2023

Investors: Bill & Melinda Gates Foundation

S

Smart Immune, hematopoietic stem cell-based biotherapies raised undisclosed on March 27, 2023

Investors: La French Tech

FAQ